Gwon A
Allergan Pharmaceuticals, Irvine, CA 92713-9534.
Br J Ophthalmol. 1992 Dec;76(12):714-8. doi: 10.1136/bjo.76.12.714.
In a double-masked, randomised, controlled study the effectiveness and safety of 0.3% ofloxacin solution were compared with those of 0.3% gentamicin ophthalmic solution in treating external bacterial ocular infections. The clinical improvement rate for patients treated with ofloxacin was 98% (51/52) and 92% (48/52) for those treated with gentamicin. Microbiological improvement was achieved in 78% (40/51) of the ofloxacin patients, compared with 67% (35/52) of the gentamicin group. Ofloxacin treatment eradicated or controlled 85% (86/101) of the Gram positive and 89% (17/19) of the Gram negative organisms cultured, compared with 83% (103/124) and 78% (29/37), respectively, after gentamicin treatment. None of these differences were statistically significant. The incidence of adverse effects attributable to ofloxacin treatment (3.2%) was less than that reported for gentamicin (7.1%). Ofloxacin proved to be an effective, safe, and comfortable therapy for external bacterial ocular infection.
在一项双盲、随机、对照研究中,比较了0.3%氧氟沙星溶液和0.3%庆大霉素眼药水治疗眼部细菌感染的有效性和安全性。氧氟沙星治疗患者的临床改善率为98%(51/52),庆大霉素治疗患者为92%(48/52)。氧氟沙星组78%(40/51)的患者实现了微生物学改善,庆大霉素组为67%(35/52)。氧氟沙星治疗根除或控制了85%(86/101)的革兰氏阳性菌和89%(17/19)的革兰氏阴性菌,庆大霉素治疗后分别为83%(103/124)和78%(29/37)。这些差异均无统计学意义。氧氟沙星治疗的不良反应发生率(3.2%)低于庆大霉素(7.1%)。氧氟沙星被证明是治疗眼部细菌感染的一种有效、安全且舒适的疗法。